IL33 and neoplasm: Moreover, consistent with our in vitro data, fluorescent immunohistochemistry (IF-IHC) and immunohistochemistry (IHC) staining revealed that cisplatin treatment significantly increased IL-33 release in tumor tissues (Fig. 7C and Supplementary Fig. S4A).